Strategies to Manage Antibody Drug Conjugates (ADC) - Related Toxicities in Breast Cancer - Episode 8
Clinical Management Considerations: Pneumonitis associated with T-DXd
Experts on breast cancer provide clinical insights on the management of pneumonitis associated with trastuzumab deruxtecan.
Video content above is prompted by the following:
- How often do you see pneumonitis in your clinical practice with trastuzumab deruxtecan (T-DXd)? Are there any potential patient risk factors for community oncologists to be aware of?
Related Content:
